Immuneering Corp·4

Feb 17, 4:16 PM ET

Hall Brett Matthew 4

4 · Immuneering Corp · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option

    2023-02-15+187,000187,000 total
    Exercise: $4.25Exp: 2033-02-15Class A Common Stock (187,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027.

Documents

1 file
  • 4
    form4-02172023_040232.xmlPrimary